Search results
Results From The WOW.Com Content Network
Original file (1,500 × 843 pixels, file size: 7.8 MB, MIME type: application/pdf, 70 pages) This is a file from the Wikimedia Commons . Information from its description page there is shown below.
During the worldwide Spanish flu pandemic of 1918, "Pharmacists tried everything they knew, everything they had ever heard of, from the ancient art of bleeding patients, to administering oxygen, to developing new vaccines and serums (chiefly against what we call Hemophilus influenzae – a name derived from the fact that it was originally considered the etiological agent – and several types ...
The following is a list of WHO recommended strains for the Northern Hemisphere influenza season. Starting in the 2012–2013 season, the recommendation shifted to include the composition of a quadrivalent influenza vaccine (QIV) that contains both influenza B lineages, alongside a trivalent influenza vaccine (TIV) containing one influenza B lineage.
A Vaccine Information Statement (VIS) is a document designed by the Centers for Disease Control and Prevention (CDC) to provide information to a patient receiving a vaccine in the United States. The National Childhood Vaccine Injury Act requires that medical professionals provide a VIS to patients before receiving certain vaccinations.
The vaccine produces a greater immune response than standard vaccine. According to the CDC, [1] "a study published in the New England Journal of Medicine [25] [in August, 2014] indicated that the high-dose vaccine was 24.2% more effective in preventing flu in adults 65 years of age and older relative to a standard-dose vaccine." The CDC ...
The second lineage of the B virus was since added to provide greater defense against circulating flu viruses. [27] Two influenza A viruses and two influenza B viruses have up until 2023 been among the four flu viruses that a quadrivalent vaccine was intended to protect against. As of 2022 all flu vaccines in the United States were quadrivalent ...
A vaccine that contains the A/Vietnam/1194/2004 (H5N1) flu strain. [28] Pumarix: A vaccine approved for medical use in the European Union in March 2011. [29] Seqirus/Audenz: A vaccine for adults that contains a killed flu strain called A/Astrakhan/3212/2020 (H5N8)-like strain. [30] Some older H5N1 vaccines for humans that have been licensed are:
In another randomized clinical trial conducted in 2014- 2015, the effectiveness of the recombinant vaccine and egg-based inactivated flu vaccine was compared in a population aged 50 or above. In contrast with the egg-based vaccine, the recombinant flu vaccine significantly reduced the risk of influenza-like illness by 30%. [13]